A Study of Empirical Antifungal Therapy With Itraconazole
- First Posted Date
- 2012-10-15
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 138
- Registration Number
- NCT01706562
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
- First Posted Date
- 2012-09-20
- Last Posted Date
- 2013-11-21
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 410
- Registration Number
- NCT01688583
An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With Epilepsy
- First Posted Date
- 2012-09-11
- Last Posted Date
- 2013-09-06
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 1234
- Registration Number
- NCT01682681
A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate
- First Posted Date
- 2012-09-10
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 154
- Registration Number
- NCT01682161
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
Completed
- Conditions
- Attention-deficit Hyperactivity Disorder
- Interventions
- First Posted Date
- 2012-06-21
- Last Posted Date
- 2015-06-09
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 289
- Registration Number
- NCT01624649
Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients
- First Posted Date
- 2012-06-18
- Last Posted Date
- 2013-09-06
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 106
- Registration Number
- NCT01621100
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug
Phase 4
Terminated
- Conditions
- Schizophrenia
- Interventions
- Drug: Paliperdidone ER
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2014-06-25
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 13
- Registration Number
- NCT01592201
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
- First Posted Date
- 2012-02-15
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 400
- Registration Number
- NCT01532895
An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2015-05-25
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 156
- Registration Number
- NCT01400633
A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2011-02-11
- Last Posted Date
- 2013-03-19
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 1700
- Registration Number
- NCT01294722
© Copyright 2025. All Rights Reserved by MedPath